2012
DOI: 10.1002/ana.23592
|View full text |Cite
|
Sign up to set email alerts
|

Biophysical stimulation induces demyelination via an integrin‐dependent mechanism

Abstract: Objective: Chronic nerve compression (CNC) injuries occur when peripheral nerves are subjected to sustained mechanical forces, with increasing evidence implicating Schwann cells as key mediators. Integrins, a family of transmembrane adhesion molecules that are capable of intracellular signaling, have been implicated in a variety of biological processes such as myelination and nerve regeneration. In this study, we seek to define the physical stimuli mediating demyelination and to determine whether integrin play… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
10
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 42 publications
(43 reference statements)
0
10
0
Order By: Relevance
“…In experimental models, both acute (Ochoa et al , 1971; Dyck et al , 1990) and chronic nerve compression (Mackinnon et al , 1984 b ) interfere with the normal architecture of nodes of Ranvier and their adjacent paranodes at the compression site, presumably by ischaemia (Nukada et al , 1985) and mechanical deformation of Schwann cells (Pham and Gupta, 2009; Lin et al , 2012). Our findings demonstrate however that such changes are not confined to the entrapment site but significantly altered axoglial relationships are confirmed in distal innervation targets.…”
Section: Discussionmentioning
confidence: 99%
“…In experimental models, both acute (Ochoa et al , 1971; Dyck et al , 1990) and chronic nerve compression (Mackinnon et al , 1984 b ) interfere with the normal architecture of nodes of Ranvier and their adjacent paranodes at the compression site, presumably by ischaemia (Nukada et al , 1985) and mechanical deformation of Schwann cells (Pham and Gupta, 2009; Lin et al , 2012). Our findings demonstrate however that such changes are not confined to the entrapment site but significantly altered axoglial relationships are confirmed in distal innervation targets.…”
Section: Discussionmentioning
confidence: 99%
“…The primary antibodies used were rabbit anti-HIF1a (1:1000 dilution; Novus Biologicals, Littleton, Colorado), mouse anti-MMP9 (1:5000 dilution; Abcam, Cambridge, Massachusetts), rabbit anti-MMP2 (1:5000 dilution; abcam), rabbit anti-superoxide dismutase (1:5000 dilution; Sigma-Aldrich, St. Louis, Missouri), mouse anti-catalase (1:5000 dilution; Sigma-Aldrich), mouse anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (1:50,000 dilution; Fitzgerald, Acton, Massachusetts), and mouse anti-tubulin (1:10,000 dilution, Sigma-Aldrich) 19,[25][26][27][28][29][30][31] . The western blotting procedure was performed at two, four, and six weeks after injury in the no-decompression groups as well as at two and six weeks after treatment in the decompression groups.…”
Section: Western Blottingmentioning
confidence: 99%
“…Briefly, 75 to 100 mg of protein was separated by 8% or 10% SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis), transferred to nitrocellulose membrane, blocked with 5% dry skimmed milk, and incubated overnight at 4°C with primary antibodies. Donkey anti-mouse secondary antibody conjugated with horseradish peroxidase (HRP, 1:10,000 dilution; EMD Millipore, Billerica, Massachusetts) or goat anti-rabbit secondary antibody conjugated with HRP (1:10,000 dilution) was used for detection 19,25 . Blot development was performed with Immobilon…”
Section: Western Blottingmentioning
confidence: 99%
See 1 more Smart Citation
“…As human tissue from early compression neuropathy is not currently available secondary to the morbidity that would occur from harvesting neural tissue in electrophysiologically confirmed compression neuropathy, these animal models are meant to provide in vivo data and findings so that we can better explore the mechanisms of this condition with in vitro models of compression neuropathy. [5][6][7] We have used this combined in vivo and in vitro modeling of compression neuropathies for the past decade to hopefully develop meaningful nonoperative treatment strategies in the coming years. 1.…”
mentioning
confidence: 99%